Here is how the process works, step by step
Manning, N
Still, with up to one million Americans affected by Parkinsons, these results are highly encouraging, and the results of a larger phase 3 trial testing another GLP-1 agonist (exenatide) as a Parkinsons treatment are expected in 2024
Fidgeting less, walking less, standing less
Some people notice benefits quickly, while others need a series of glutathione treatments as part of a larger health plan
The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them. Although the study is not representative of the broader populationReddit users are generally younger, more likely male and based in the U.S.the symptoms reported collectively match known side effects of semaglutide and tirzepatide